Cellular Goods Share Price (CBX)

[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Cellular Goods Plc LSE:CBX London Ordinary Share GB00BK964W87 ORD GBP0.001
  Price Change % Change Share Price Shares Traded Last Trade
  -0.375 -4.62% 7.75 7,953,652 16:35:15
Bid Price Offer Price High Price Low Price Open Price
7.65 7.75 8.125 7.425 8.125
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Personal Goods 39
Last Trade Time Trade Type Trade Size Trade Price Currency
16:35:15 O 340,000 8.026 GBX
Related Shares
Burberry (BRBY), Pz Cussons (PZC), Eve Sleep (EVE), Pittards (PTD)

Cellular Goods (CBX) Latest News (6)

Cellular Goods News

Date Time Source Headline
03/12/202112:21ALNCCellular Goods shares slip as loss widens on start-up and IPO costs
03/12/202107:00UKREGCellular Goods PLC Annual results
01/12/202121:43ALNCTRADING UPDATES: Honye Financial loss widens; Highway loss narrows
01/12/202106:59UKREGCellular Goods PLC Launch of inaugural products & ecommerce platform
11/11/202107:00UKREGCellular Goods PLC Advertising and PR agencies appointed
08/11/202114:05UKREGCellular Goods PLC Second Price Monitoring Extn
08/11/202114:00UKREGCellular Goods PLC Price Monitoring Extension
08/11/202111:05UKREGCellular Goods PLC Second Price Monitoring Extn
08/11/202111:00UKREGCellular Goods PLC Price Monitoring Extension
01/11/202107:00UKREGCellular Goods PLC Grant of Share Options and update on warrants
More Cellular Goods News
Cellular Goods Investors    Cellular Goods Takeover Rumours

Cellular Goods (CBX) Discussions and Chat

Cellular Goods Forums and Chat

Date Time Title Posts
03/12/202109:18CBX with Charts & News327
18/8/202116:56Cellular goods consumer cannabis1,015
17/5/202105:36Share Tip Buddy -
26/4/202114:56New gambling stock126

Add a New Thread

Cellular Goods (CBX) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
17:15:008.03340,00027,288.40O
17:15:008.28300,00024,847.50O
17:15:008.16490,00039,984.00O
16:35:157.7574,7215,790.88UT
16:29:517.693,153242.31O
View all Cellular Goods trades in real-time

Cellular Goods (CBX) Top Chat Posts

DateSubject
03/12/2021
08:20		Cellular Goods Daily Update: Cellular Goods Plc is listed in the Personal Goods sector of the London Stock Exchange with ticker CBX. The last closing price for Cellular Goods was 8.13p.
Cellular Goods Plc has a 4 week average price of 6.71p and a 12 week average price of 5.13p.
The 1 year high share price is 27.50p while the 1 year low share price is currently 5.13p.
There are currently 504,750,000 shares in issue and the average daily traded volume is 9,050,923 shares. The market capitalisation of Cellular Goods Plc is £39,118,125.
Read Full Thread
Reply
02/12/2021
10:05		whites123: having held at a paper loss for months, i sold out 900,000 shares yesterday absorbing a loss of some £27,000 i sincerely hope that it comes good, but after having so much hope and support for cbx the offering, the packaging, the lack of advertising suggest to me it just will not survive in a market of cbd goods that is growing exponentially. the price range is in the medium zone, yet the packaging suggests it as obtained at a 50p stall on a flea market. the market place for these goods is saturated to overflowing point. handpickedcbd.co.uk has so many companies touting these similar products that there is absolutely nothing at all to warrant the higher price being charged by cbx. OCTP: Oxford Cannabinoid flipside of the coin, an where i added some shares yesterday (Another 2 million shares added making my holding 5 million) was OCTP. a company that has a medical license granted for cannabinoid products. not just cbd but specialist medical license. targeting real life needs for pain relief, and the medicinal market. share holders like FTSE 100 British multinational tobacco company Imperial Brands Ventures Limited which holds 10% today directors who are on at best mediocre pay packages dipped their hands into their own pockets to buy shares. yesterday the US OTC listing which will improve liquidity. The clear out of old advisors to be replaced by the excellent harbor access. and still the price is 50% of the IPO listing price. i had to make the decision. what do i think will do best. targeting medical issues like pain from cancer or appealing to face cream markets with products that resemble 50p bottles of moisturising creams. I hope I have made the right decisions and may look in on cbx to see if its still here in a year.
Read Full Thread
Follow
Reply
01/12/2021
08:58		whites123: CBX is a great one.. I hold CBX, but I also hold OCTP and 2 RNS in the space of hours. I did implore you guys to research OCTP. From the pitiful rise it looks like majority of you did not. Masses of opportunity still. Its still 50% less than IPO price.. Last nights RNS was welcomed. This mornings RNS was expected. Both fantastic news. Clear out of old advisors who having overseen the IPO listing have watched the shares fall to less than 50% of that IPO price.. Brilliant news. A few weeks ago the appointment of North American advisors "Harbor Access" A clear out of old dead wood (Non Exec Director) New partnerships.. A rebound to well above 5p (8 to 9p) just to put it on even par with subsequent cannabinoid listings. Except, OCTP has the attention of everyone because it deals with pain relief in those with awful diseases such as cancer.... The Americans will now be able to trade this stock and with Harbor Access doing the PR i foresee this rocketing in the next few months to an share price and MC of a company more worthy of a 10 bagger price.
Read Full Thread
Follow
Reply
01/12/2021
07:28		david gruen: 1 December 2021 Cellular Goods PLC ("Cellular Goods" or "the Company") Launch of inaugural product range and ecommerce platform Cellular Goods (LSE: CBX), a UK-based provider of premium consumer products formulated with lab-made cannabinoids, is pleased to announce the launch today of its inaugural product ranges and ecommerce platform, found at cellulargoods.co. The launch comprises two product ranges and comes just nine months after the start-up of the Company's commercial operations following its flotation on the London Stock Exchange. The inaugural range comprises the UK's first premium CBG (cannabigerol) skincare offering including a serum, a face-oil and an after-shaving moisturiser. The products contain ultra-pure, biosynthetic CBG, which has demonstrated anti-inflammatory, anti-oxidant and anti-bacterial properties. All three products have been through an extensive testing process and are fully validated for marketing and labelling as suitable for sensitive skin, dermatologically tested and dermatologist approved. The second range is a clinically validated CBD (cannabidiol) ingestibles range. This range complies with novel food regulations in both the UK and the EU and is certified under Good Manufacturing Practice (GMP) standards. The ingestibles range comprises a tincture, a spray and capsules, covering the most popular methods of consumption. These have been extensively tested to ensure safety, stability and quality. Both product ranges do not require the cultivation of the cannabis sativa plant, and contain 0% THC, the psychoactive component of cannabis sativa. In addition, the Company's new ecommerce platform has gone live, enabling customers in the UK to place online purchase orders for five of the six products as of today. The skincare serum will go on sale from February 2022 due to supply constraints at the Company's manufacturing partner until early in the new year. Alexis Abraham, Chief Executive of Cellular Goods, commented: "Today is a major milestone for the Company with the launch of the UK's first CBG skincare products on a best-in-class ecommerce platform. Leading with CBG sets us apart from the competition, and to also be able to offer consumers CBD ingestibles at the same time delivers on our vision to become the first true cannabinoid company. We have taken less than a year from a standing start to put Cellular Goods at the forefront of the cannabinoid and wellness industries, and as of today, we have started a new chapter in our growth by entering a revenue-generating phase. Consumers are now familiar with CBD, and we believe there is a substantial and growing demand for a more innovative and premium brand offering clean, green, and compliant products and look forward to delivering on our potential".
Read Full Thread
Follow
Reply
29/11/2021
13:13		whites123: n0rbie, I would recommend researching OCTP if you have an interest in cannabinoids providing pain relief for diseases including cancer Agreements with top scientific bodies. Great shareholder base, means likely no requirement to need to go to market for funding. OTC listing in the States very soon. Less than 50% of IPO Clear out of Directors and Non Exec to ensure full alignment and focus on future. One could and should research any of the above. The announcement of researching pain relief in Oncology (Cancer) is welcomed by millions the globe over. Who doesnt know someone who has cancer and benefits from the pain relief THC provides? The share price has been smashed because of the liquidity. Today just small share purchases and the share price rockets. Stick a Million or more shares away for the kids and the likelihood is in a few years time they will never have to work a day in their lives. 10 bagger is more likely to be replaced with 100 bagger if just one of the cannabinoids show to work, and we KNOW they work.. Cannabis works for pain.. we know it does, now we just need the scientific proof and its availability to all.
Read Full Thread
Follow
Reply
28/11/2021
19:31		kickingking: Back when CBX launched on the market, the early investors were offered a free product sample when it was launched. Anyway received email stating that they will replace the free sample with a 25 pound voucher instead. It seems like the products are not going to be cheap.Hopefully plenty of product are sold and price goes back to 20p+
Read Full Thread
Follow
Reply
19/11/2021
08:53		oapknob1: CBX doesn't have historic natural resources assets they haven't yet disposed of dragging them back. CHLL we're at a much higher share price before driving off a cliff. Both companies have potential but with different products. Once CHLL disposes of the historical baggage it's a whole different proposition.
Read Full Thread
Follow
Reply
19/11/2021
07:35		alloa2003: While I think this is just early days for this type of product I'm not sure about some of the comments suggesting the big players will come in and take CBX out at some point. Why wouldnt they just set up their own range using their reputational leverage? However, maybe the regulatory clearance CBX has for its growing range of products has a value in itself? Happy to be educated on this if I am wrong.
Read Full Thread
Follow
Reply
11/11/2021
08:22		kirk 6: No it's not! it's confirmed the launch in December with no more delays and the marketing strategy. Jam tomorrow ? What does that mean Today's news is excellent in confirming the run-up to Christmas and beyond into 2022.There is plenty of news to come and huge upside for the share price
Read Full Thread
Follow
Reply
04/11/2021
09:55		kirk 6: Yep Q1 2022 will potentially be transformational for the share price
Read Full Thread
Follow
Reply
05/10/2021
19:44		kirk 6: Are you messing ? Dyor they are bringing a plethora of products to the market in December. The director bought 2m shares yesterday and now holds over 4m shares will leads me to believe future share dilution will be minimal if any!! This is by far the best cannabis play in my opinion. Target share price many multiples of current MKP
Read Full Thread
Follow
Reply
Cellular Goods share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
CBX
Cellular G..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211203 17:34:15